6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Leave a Reply

You must be logged in to view and post comments.

Since the COVID-19 pandemic began on March 11, 2020, there has been concern that survivors might be at an increased risk of neurological disorders. This concern, initially based on findings from other coronaviruses, was followed rapidly by case series, emerging evidence of COVID-19 CNS involvement, and the identification of mechanisms by which this could occur. Similar concerns have been raised regarding psychiatric sequelae of COVID-19, with evidence showing that survivors are indeed at increased risk of mood and anxiety disorders in the 3 months after infection. However, we need large-scale, robust, and longer-term data to properly identify and quantify the consequences of the COVID-19 pandemic on brain health.

Leave a Reply

Subscribe to Comments RSS feed